We are proud to announce that we have officially joined forces with Preventative Technology Solutions, who will now become apart of the cliexa family.
Here is the link to the press release about the acquisition: //www.pr.com/press-release/768313
cliexa® partners with the Colorado Arthritis Center to identify how screening and monitoring of Rheumatoid Arthritis patients through a customized electronic platform, cliexa-RA, impacts clinical efficiency.
See the full press release from PR.com: https://www.pr.com/press-release/765307
Download the Case Study here: https://www.cliexa.com/cliexa-ra-case-study/
Learn more about cliexa-RA: https://www.cliexa.com/cliexamobile/rheumatoid-arthritis/
On August 27-29, members of the cliexa team, including founder and CEO Mehmet Kazgan, will be attending the Health:Further Conference in Nashville, TN.
The cliexa booth will be in Entrepreneur’s Alley to demo our platforms, and solutions. Angie Buckley, our Director of Business Development, and Ashley Darnell, our Product Manager, are experts at everything cliexa, and will be there everyday. Don’t be shy, come say hello!
This annual healthcare innovation conference is expected to bring in over 2,000 attendees from various healthcare companies, start-ups, and many investors. Health:Further was started in 2015 by Jumpstart Foundry, who selected cliexa as one of their 2018 portfolio companies. cliexa will be accompanied by other avant-garde companies at the conference, such as Vend.RX, Doc&I, LevelTherapy, and more!
If you are attending the conference, we’d love to meet you, and help you learn more about what we do! Find us on the Health:Further mobile app, and reach out to us through direct message. Our team will be available to answer questions. If you cannot find us at the conference, or will not be attending and still want to learn more about what we do, please feel free to contact us! Hope to see you there!
Managing rheumatoid arthritis (RA) can be exhausting in itself. You’re likely juggling medications, doctor appointments, and various lifestyle changes. Since the condition affects people differently and can change from month to month, it’s important to keep track of your symptoms and how you respond to treatments. Having good records can be helpful for your healthcare team.
cliexa-RA has been featured as one of the Best Rheumatoid Arthritis Apps of 2018!
https://www.healthline.com/health/best-ra-apps
cliexa® partners with the University of Colorado Boulder’s Cognitive and Affective Neuroscience Lab (CANLab) for Multidimensional Pain Tracking and Predictive Analytics Research.
Denver, CO, February 28, 2018 — cliexa, Inc., which offers a suite of mobile platforms for chronic disease management, announces its collaboration with CU Boulder’s CANLab and Institute of Cognitive Science (ICS). cliexa will collaborate with CANLab’s team, headed by Tor Wager, a professor of psychology and neuroscience, as they lead in multidimensional pain tracking and predictive analytics research.
CU Boulder jointly filed a provisional patent with cliexa for the multidimensional objective pain concept with CANLab. CANLab focuses on identifying a particular pattern of brain activity, which is diagnostic of physical pain. cliexa-Ease’s mobile platform hosts the research concept and is being used to further develop CANLab’s existing pain studies. cliexa-Ease will deliver an exclusive pain assessment model which, in collaboration with CU Boulder, anticipates commercialization by mid 2018.
Mehmet Kazgan, founder and CEO of cliexa, explains how they are excited about the partnership with Wager’s CANLab because of its “leading research studies for multidimensional pain tracking.” “Working with neuroscientists at CU Boulder is taking the cliexa platform to the next level of objectifying patient outputs with multiple reference points.”
Wager highlights how the collaboration will “expand our ability to understand how emotion affects pain in daily life.” Pavel Goldstein, the scientific lead of the project, adds that the partnership will provide both “an incredible opportunity to establish a platform for researching chronic pain conditions” and “important feedback to pain patients and their clinicians with unique information about patient health.”
About The Cognitive and Affective Neuroscience Lab
Professor Tor Wager leads CANLab, which is housed in CU Boulder’s Institute of Cognitive Science (ICS) and the Psychology and Neuroscience Department. CANLab uses machine-learning to develop fMRI-based biomarkers for clinically relevant outcomes, such as pain. It subsequently tests how psychological factors influence these biomarkers. The lab also engages in collaborative, translational research, which incorporates brain systems-level analyses into the study of clinical disorders, including PTSD, depression, schizophrenia, and chronic pain.
Learn more about CAN Lab at https://canlabweb.colorado.edu
About cliexa
The mobile platform technology developed by cliexa enables patients to track their chronic disease activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models. cliexa delivers quantified disease activity and medication adherence through patient reported outcomes through real-time integration to electronic medical records, which streamline processes and increase efficiency in population health management.
Learn more about cliexa at https://www.cliexa.com
See the Press release here: